Avanzando en la seguridad del paciente con multimorbilidad y polimedicación: herramientas explícitas para las interacciones fármaco-fármaco

Daniel Sevilla-Sánchez

doi:10.7399/fh.11738

Avanzando en la seguridad del paciente con multimorbilidad y polimedicación: herramientas explícitas para las interacciones fármaco-fármaco

Daniel Sevilla-Sánchez

Resumen

Texto completo:

PDF (English) PDF

Referencias

Mangoni AA, Jarmuzewska EA. Incorporating pharmacokinetic data into personalised prescribing for older people: challenges and opportunities. Eur Geriatr Med. 2021;12:435-42. DOI: 10.1007/s41999-020-00437-5

Xing XX, Zhu C, Liang HY, Wang K, Chu YQ, Zhao LB, et al. Associations Between Potentially Inappropriate Medications and Adverse Health Outcomes in the Elderly:A Systematic Review and Meta-analysis. Ann Pharmacother. 2019;53:1005-19. DOI: 10.1177/1060028019853069

Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825-32. DOI: 10.1001/archinte.1991.00400090107019

Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VMV. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74:679-700. DOI: 10.1007/s00228-018-2446-0

Anrys P, Petit AE, Thevelin S, Sallevelt B, Drenth C, Soiza RL, et al. An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People. J Am Med Dir Assoc. 2021:S1525-8610(21)00315-7. DOI: 10.1016/j.jamda.2021.03.019

De Oliveira LM, Diel JDAC, Nunes A, da Silva Dal Pizzol T. Prevalence of drug interactions in hospitalised elderly patients: a systematic review. Eur J Hosp Pharm. 2021;28:4-9. DOI: 10.1136/ejhpharm-2019-002111

Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness✩. J Clin Epidemiol. 1992;45:1045-51. DOI: 10.1016/0895-4356(92)90144-C

Dechanont S, Maphanta S, Butthum B, Kongkaew C. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2014;23:489-97. DOI: 10.1002/pds.3592

Liau SJ, Lalic S, Sluggett JK, Cesari M, Onder G, Vetrano DL, et al. Medication Management in Frail Older People: Consensus Principles for Clinical Practice, Research, and Education. J Am Med Dir Assoc. 2021;22:43-9. DOI: 10.1016/j.jamda.2020.05.004

Beuscart JB, Knol W, Cullinan S, Schneider C, Dalleur O, Boland B, et al. International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med. 2018;16:21. DOI: 10.1186/s12916-018-1007-9

De Oliveira Santos Silva R, Macêdo LA, Dos Santos GA, Aguiar PM, De Lyra DP. Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews. PLoS One. 2019;14:e0210312. DOI: 10.1371/journal.pone.0210312

Sinha IP, Smyth RL, Williamson PR. Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies. PLoS Med. 2011;8:e1000393. DOI: 10.1371/journal.pmed.1000393

McCarthy LM, Visentin JD, Rochon PA. Assessing the Scope and Appropriateness of Prescribing Cascades. J Am Geriatr Soc. 2019;67:1023-6. DOI: 10.1111/jgs.15800

DOI: http://dx.doi.org/10.7399%2Ffh.11738